STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY

被引:0
|
作者
Sivakami [1 ]
Kannan, Indhu [1 ]
Madhusudhanan [1 ]
机构
[1] Meenakshi Mission Hosp & Res Ctr, Dept Pathol, Madurai, Tamil Nadu, India
来源
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS | 2018年 / 7卷 / 49期
关键词
Breast Cancer; Infiltrating Ductal Carcinoma (NOS) HER 2 Gene Immunohistochemistry Fluorescence; in Situ Hybridization;
D O I
10.14260/jemds/2018/1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Breast cancer has surpassed all other cancers in women becoming the leading cause for mortality. 100 breast cancer cases received in our department of pathology during the period 2016-2017 were evaluated for HER2/neu status and immunohistochemistry correlation with gene amplification by FISH assay. MATERIALS AND METHODS Mastectomy samples received were fixed followed by grossing including all parameters like laterality, size, margin status and adequate lymph node sampling. The tissue sections were stained with H&E for assessing the tumour type, grade, surgical margin clearance study. Lymph node involvement, oestrogen receptor and progesterone receptors Her2/neu was done with immunohistochemistry in the tumour blocks. Subsequently tissue blocks were also subjected to FISH evaluation for Her2/neu. RESULTS The tumour laterality, tumour categorization, staging, and grading were analysed. Comparison of immunohistochemical Her2 results with FISH was done. CONCLUSION Immunohistochemical analysis of Her2/neu with 0 and 1+ Negative. 3+ strong positive had a High concordance with FISH evaluation.
引用
收藏
页码:5298 / 5303
页数:6
相关论文
共 50 条
  • [31] HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
    Han Zhang
    Guoping Ren
    Xiaoling Wang
    Jing Zhao
    Hongtian Yao
    Yanfeng Bai
    Wang Bo
    Breast Cancer Research and Treatment, 2012, 134 : 743 - 749
  • [32] Her2 Amplification Status in Iranian Breast Cancer Patients: Comparison of Immunohistochemistry (IHC) and Fluorescence in situ Hybridisation (FISH)
    Ghaffari, Saeed Reza
    Sabokbar, Tayebeh
    Dastan, Jila
    Rafati, Maryam
    Moossavi, Shirin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 1031 - 1034
  • [33] Correlation of HER2 gene amplification with immunohistochemistry in breast cancer as determined by a novel monoplex polymerase chain reaction assay
    Willmore, C
    Holden, JA
    Layfield, LJ
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (04) : 333 - 341
  • [34] Comparison of Silver-Enhanced in situ Hybridization and Fluorescence in situ Hybridization for HER2 Gene Status in Breast Carcinomas
    Kang, Jun
    Kwon, Gui Young
    Lee, Young-Hee
    Gong, Gyungyub
    JOURNAL OF BREAST CANCER, 2009, 12 (04) : 235 - 240
  • [35] IMMUNOHISTOCHEMICAL HER-2/NEU EXPRESSION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSESSMENT IN BREAST CARCINOMAS
    Moatter, Tariq
    Zeeshan-ud-din
    Khilji, Zahida Latif
    Murad, Farzana
    Kayani, Naila
    Pervez, Shahid
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (12): : 726 - 730
  • [36] Analysis of the HER2/neu gene amplification in microdissected breast cancer tumour samples
    Seth, RM
    Burger, AM
    Kahn, HJ
    ANTICANCER RESEARCH, 2006, 26 (2A) : 927 - 931
  • [37] Concordance of immunohistochemistry and fluorescence in situ hybridization for assessment of HER2 status in breast cancer patients in Xinjiang autonomous region, China
    Zhao, Bing
    Wang, Yu
    Xu, Hang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (10): : 10459 - 10466
  • [38] Determination of Her-2/neu status in breast carcinoma:: Comparative analysis of immunohistochemistry and fluorescent in situ hybridization
    Jimenez, RE
    Wallis, T
    Tabasczka, P
    Visscher, DW
    MODERN PATHOLOGY, 2000, 13 (01) : 37 - 45
  • [39] Cost-effectiveness of a Dual (Immunohistochemistry and Fluorescence In Situ Hybridization) HER2/neu Testing Strategy on Invasive Breast Cancers
    Hariri, Nosaibah
    Zare, Somaye
    Murphy, James
    Fadare, Oluwole
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (01) : 42 - 48
  • [40] Effect of EDTA decalcification on estrogen receptor and progesterone receptor immunohistochemistry and HER2/neu fluorescence in situ hybridization in breast carcinoma
    Washburn, Erik
    Tang, Xiaoyu
    Caruso, Carla
    Walls, Michelle
    Han, Bing
    HUMAN PATHOLOGY, 2021, 117 : 108 - 114